Antibody Basics: Hybridoma Development

Hybridoma technology is the core technique that is used for monoclonal antibody development. By isolating B-cells from mice and fusing them with tumor cells, immortal cell lines are able to be grown and used for production purposes. Learn more about hybridoma protocol on ProSci's blog.

September 2015: Antibody Update

The September Antibody Update includes news on an antibody targetting HIV glycoproteins at different conformations, a paper on humanized monoclonal antibodies against clostridium difficile finishing phase 3 clinical trials, and the study of a human endogenous retrovirus that may reveal understanding of ALS.

ProSci's Antibody Expert's Published in Vaccine!

Last month, the latest ProSci research on the HIV vaccine development was published in the scientific journal Vaccine. Here is a background on the work ProSci has done developing a vaccine against the HIV glycoproteins.

 August 2015: The Antibody Update

August's Antibody Update looks at Cornell University's "Shuffle" method of mimicking primary imune responses in vitro.